OAM
NKTR icon

Oxford Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Oxford Asset Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,135
Closed -$11.6K – 684
2025
Q1 		$11.6K Buy
+1,135
New +$14.8K 0.01% 466
2020
Q1 		– Sell
-5,083
Closed -$1.65M – 912
2019
Q4 		$1.65M Buy
+5,083
New +$1.47M 0.05% 543
2019
Q1 		– Sell
-3,872
Closed -$1.91M – 1875
2018
Q4 		$1.91M Buy
3,872
+2,178
+129% +$1.31M 0.05% 492
2018
Q3 		$1.54M Buy
+1,694
New +$1.45M 0.03% 806
2017
Q2 		– Sell
-9,578
Closed -$3.37M – 1625
2017
Q1 		$3.37M Sell
9,578
-2,882
-23% -$648K 0.08% 243
2016
Q4 		$2.29M Sell
12,460
-21,527
-63% -$4.38M 0.08% 288
2016
Q3 		$8.76M Buy
33,987
+11,201
+49% +$2.88M 0.27% 86
2016
Q2 		$4.86M Buy
22,786
+4,873
+27% +$1.09M 0.16% 151
2016
Q1 		$3.69M Buy
17,913
+2,693
+18% +$517K 0.11% 243
2015
Q4 		$3.87M Buy
15,220
+11,928
+362% +$2.45M 0.09% 240
2015
Q3 		$541K Buy
+3,292
New +$582K 0.02% 485
2014
Q1 		– Sell
-3,632
Closed -$618K – 726
2013
Q4 		$618K Sell
3,632
-1,030
-22% -$166K 0.02% 568
2013
Q3 		$731K Sell
4,662
-5,127
-52% -$948K 0.02% 613
2013
Q2 		$1.7M Buy
+9,789
New +$1.5M 0.05% 485

Other funds holding NKTR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Oxford Asset Management's NKTR Position: Q2 2025 in Review

Oxford Asset Management sold out of Nektar Therapeutics (NKTR) in Q2 2025, closing a stake of 1,135 shares — an estimated $11.6K sold.

Oxford Asset Management first reported a position in NKTR in Q2 2013 and held it in 14 quarters. The position peaked at $8.76M in Q3 2016. 109 funds tracked by Wall St. Rank hold NKTR as of Q2 2025.

  • Oxford Asset Management reported no remaining Nektar Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Oxford Asset Management sold 1,135 Nektar Therapeutics shares in Q2 2025, an estimated $11.6K.
  • Oxford Asset Management first reported a position in Nektar Therapeutics in Q2 2013 and held it in 14 quarters.
  • Oxford Asset Management's Nektar Therapeutics position peaked at $8.76M in Q3 2016.
  • 109 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2025.

Based on Oxford Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.